Primary outcomes: CD4+ or CD8+ T-cell count and CD4/CD8 ratio
Concerning the primary endpoint of absolute values and change in CD4+ or CD8+ T lymphocyte count and in CD4/CD8 ratio, no evidence for a difference by study arm was found either at 6 (T6) or at 12 months (T12) after the switch (T0). All these three main immunological parameters tended to remain stable over time in both arms (Primary endpoints by study arm—adjusted analysis.RCT, randomized clinical trial; VL, viral load.

Primary endpoints (change) by study arm—adjusted analysis.RCT, randomized clinical trial; VL, viral load.

